Kyntra Bio Inc (KYNB) Stock Price & News

Symbols Symbols	Price	Change	% Change	Trend	Prev Close	Open	High	Low	Volume	Mkt Cap
SIXB Materials SIXB Materials	SIXB -2.31%	1,041.53	-24.68	-2.31%	—	1,066.21	1,064.94	1,064.94	1,038.77	—	—
SIXC Communications SIXC Communications	SIXC -0.97%	605.26	-5.90	-0.97%	—	611.16	611.16	612.25	604.78	—	—
SIXE Energy SIXE Energy	SIXE +1.01%	1,282.74	+12.81	+1.01%	—	1,269.93	1,273.16	1,287.58	1,262.69	—	—
SIXI Industrials SIXI Industrials	SIXI -1.17%	1,700.27	-20.14	-1.17%	—	1,720.41	1,717.39	1,717.39	1,694.47	—	—
SIXM Financials SIXM Financials	SIXM -1.23%	629.31	-7.82	-1.23%	—	637.13	637.40	637.74	628.83	—	—
SIXR Staples SIXR Staples	SIXR +0.18%	867.83	+1.58	+0.18%	—	866.25	865.77	874.12	858.72	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +0.43%	215.57	+0.93	+0.43%	—	214.64	214.64	216.08	213.49	—	—
SIXT Technology SIXT Technology	SIXT -0.66%	3,487.87	-23.26	-0.66%	—	3,511.13	3,481.07	3,527.59	3,440.20	—	—
SIXU Utilities SIXU Utilities	SIXU +0.99%	895.72	+8.80	+0.99%	—	886.92	885.23	896.83	881.74	—	—
SIXV Health care SIXV Health care	SIXV +1.09%	1,486.47	+15.98	+1.09%	—	1,470.49	1,470.68	1,494.42	1,462.16	—	—
SIXY Discretionary SIXY Discretionary	SIXY -1.12%	2,323.57	-26.20	-1.12%	—	2,349.77	2,332.17	2,332.17	2,307.43	—	—

KYNB:NASDAQ

Kyntra Bio Inc

$6.80

-0.44%

(-0.030) 1D

May 19, 4:00:01 PM GMT-4 · USD

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for KYNB...

Open

$6.78

High

$6.90

Low

$6.78

Mkt. cap

27.53M

Avg. vol.

9.91K

Volume

11.01K

52-wk high

$9.70

52-wk low

$6.32

EPS

-$14.40

Beta

1.04

Shares outstanding

4.05M

No. of employees

Related stocks

Atara Biotherapeutics Inc

News stories

From sources across the web

Investing.com

2 hours ago

Kyntra Bio CEO Thane Wettig buys $19,852 in stock

Stock Titan

3 hours ago

KYNTRA BIO (KYNB) CEO Thane Wettig adds 2,800 shares in open-market buy

TipRanks

19 hours ago

Kyntra Bio Rocked by CEO’s Sudden Insider Stock Sale

Investing.com Australia

1 day ago

Kyntra Bio CEO Thane Wettig buys $19,852 in company stock By Investing.com

Profile

Kyntra Bio, Inc. is a biopharmaceutical company headquartered in San Francisco, California. Once regarded as a promising developer of innovative therapies for anemia and fibrotic diseases, with a market capitalization of roughly $4 billion in 2018–19, the company's value collapsed following late-stage trial failures, regulatory setbacks, and a data manipulation scandal. By 2026, Kyntra was mainly reduced to a single early-stage oncology drug candidate. On January 8, 2026, FibroGen changed its name to Kyntra Bio and ticker symbol to KYNB. Wikipedia

About Kyntra Bio Inc

CEO-

Employees34

FoundedJan 1, 1993

HeadquartersSan Francisco, California, United States

SectorBiotechnology

Websitefibrogen.com

All values in USD	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	1.35M	1.08M	1.28M	3.74M
Cost of goods sold	5.95M	1.15M	7.55M	4.11M
Cost of revenue	5.95M	1.15M	7.55M	4.11M
Research and development expenses	-	-	-	7.57M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	7.06M	5.30M	7.25M	5.86M
Operating expense	7.06M	5.30M	7.25M	13.43M
Total operating expenses	13.01M	6.45M	14.80M	17.53M
Operating income	-11.66M	-5.37M	-13.52M	-13.80M
Other non operating income	-	-	-	1.11M
EBT including unusual items	-13.78M	-13.15M	-14.61M	-15.13M
EBT excluding unusual items	-13.38M	-6.52M	-14.62M	-15.11M
Income tax expense	-92.00K	-	-	-
Effective tax rate	0.67%	-	-	-
Other operating expenses	-	-	-	-
Net income	-7.60M	200.64M	-14.22M	-15.20M
Net profit margin	-564.02%	18,646.47%	-1,113.55%	-406.58%
Earnings per share	-1.88	49.61	-3.51	-3.76
Interest and investment income	286.00K	931.00K	1.32M	-
Interest expense	-2.01M	-2.08M	-2.41M	-2.43M
Net interest expenses	-1.72M	-1.15M	-1.10M	-2.43M
Depreciation and amortization charges	-	-	-	-
EBITDA	-11.44M	-5.18M	-13.51M	-13.61M
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research